[Initial results of a clinical trial of Mebacid (sulfamerazine) in the drug therapy of bacterial meningitis].
D000293:Adolescent; D001424:Bacterial Infections / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000378:metabolism; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D010400:Penicillin G / Q000627:therapeutic use; D013416:Sulfamerazine / Q000378:metabolism / Q000627:therapeutic use*
D010400:Penicillin G; D013416:Sulfamerazine
Erste Ergebnisse der klinischen Erprobung von Mebacid (Sulfamerazin) als Chemotherapeutikum bakterieller Meningitiden.